Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 6NETWORK 2INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Osteoporosis 1Esophageal Neoplasms 1Carcinoma, Squamous Cell 1Breast Neoplasms 1Bone Diseases, Metabolic 1Adenocarcinoma 1

Interventions

Zoledronic Acid 4Letrozole 2Kyphoplasty 2Denosumab 2Toremifene 1Testosterone 1Risedronic Acid 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Osteoporosis × Risedronic Acid × Clear all
NCT00082277 2011-01-26

SABRE

AstraZeneca

Phase 4 Completed
237 enrolled
Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡